Norwood Immunology Limited Starts BMT Phase II Clinical Trial
Published: Feb 21, 2006
Norwood Immunology Limited said Tuesday that it has commenced Phase II clinical trial in cancer patients undergoing autologous (self-derived) bone marrow transplant (BMT).